Current funding:
British Skin Foundation PhD studentship (2020 – 2023)The control of the gap junction protein Connexin 43 in normal keratinocytes and healing wounds. awarded Prof Sheila Graham (University of Glasgow https://www.gla.ac.uk/researchinstitutes/iii/staff/sheilagraham/) and Dr Patricia Martin We are delighted to welcome PhD student Harry Scott to the team who will be working jointly between UoG and GCU. https://www.britishskinfoundation.org.uk/bsf-research-funding #Connexins .
SULSA Optical Imaging Proof of Principle funding (2019-2021)Skin Deep: New mesoscopic imaging of large tissue volumes at high resolution awarded to Dr Patricia Martin and Professor Gail McConnell (University of Strathclyde https://www.strath.ac.uk/staff/mcconnellgailprof/ ). Industrial partner Tissue Solutions https://www.tissue-solutions.com/. We are accessing human skin from the tissue bank with a view to image at high resolution large tissue volumes of normal and diseased skin. GCU matched funded this grant to support the tissue bank and our Research Assistant Dr Boatemaa Ofori-Frimpong.
SULSA ECR development award 2020 (funding period: February- June 2021)
The GCU Tissue Bank and Mesoscopic deep imaging of human tissue. Awarded to Dr Boatemaa Ofori-Frimpong.
Other current PhD students:
Roan Permadhi (GCU) (2021-2025) – Fibrosis in Diabetes Mellitus: The role of Insulin-like Growth Factor Binding Proteins.
International collaborations:
We have supplied tissue to Prof A Baker, University of Texas Austin with several significant publication outputs related https://www.bme.utexas.edu/people/faculty-directory/baker.
Some previous funding:
Animal Free Research (2014-2017)
Improving access to human material for diabetes research. Awarded to Prof Ann Graham and Dr Catherine Wright
https://www.animalfreeresearchuk.org/project/improving-access-to-human-material-for-diabetes-research/
Psoriasis Association PhD studentship (2015-2018)
A role for connexin-mediated signalling events in the pathogenesis of psoriasis. Awarded to Dr Patricia Martin and Dr Mozheh Zamiri (consultant dermatologist). PhD student Erin O’Shaughnessy
https://www.psoriasis-association.org.uk/research/researchresults
We hold tissue blocks from >50 individuals (diabetic and non-diabetic) and a stock of derived keratinocytes and fibroblasts available for medical research. We have access to matched proximal and distal leg biopsies from diabetic and normal patients undergoing vascular lower limb bypass surgery.
Our ethics covers the following applications:
- Fixed, wax embedded skin tissue
- Primary dermal fibroblasts
- Primary epidermal keratinocytes
- Frozen skin tissue for DNA, RNA or protein extraction
- Generation of iPS cells from patient related material
Please get in touch to request an application form for access to samples. Applications will be assessed by the GCU Skin Research Tissue Bank Committee and approved on the basis of their scientific merit.
There is no charge for access to samples but applicants are expected to cover transport costs and supply appropriate customs declarations where necessary. Successful applicants are also expected to provide annual research updates and include an acknowledgement in all publications using material supplied by the tissue bank. Further details are available on request.
1. Bastaki KM, Tarlton JMR, Lightbody RJ, Graham A, Martin PE: Homo Sapiens (Hsa) -microRNA (miR)-6727-5p Contributes to the Impact of High –Density Lipoproteins on Fibroblast Wound Healing In Vitro. Membranes 2022,12(2):154.
2. O’Shaughnessy EM, Duffy W, Garcia-Vega L, Hussey K, Burden AD, Zamiri M, Martin, PE. Dysregulation of Connexin Expression Plays a Pivotal Role in Psoriasis. International Journal of Molecular Sciences. 2021;22(11):6060. Doi doi:10.3390/ijms22116060
3. Takematsu E, Auster J, Chen P-C, Srinath S, Canga S, Singh A, Majid M, Sherman M, Dunn A, Graham A et al: Transmembrane Stem Cell Factor Protein Therapeutics Enhance Revascularization in Ischemia without Mast Cell Activation. bioRxiv 2020:2020.2004.2006.028563.
4. Takematsu E, Spencer A, Auster J, Chen PC, Graham A, Martin P, Baker AB: Genome wide analysis of gene expression changes in skin from patients with type 2 diabetes. PLoS One 2020, 15(2):e0225267.
5. Martin PE, O'Shaughnessy EM, Wright CS, Graham A: The potential of human induced pluripotent stem cells for modelling diabetic wound healing in vitro. Clin Sci (Lond) 2018, 132(15):1629-1643.
6. Faniku C, O'Shaughnessy E, Lorraine C, Johnstone SR, Graham A, Greenhough S, Martin PEM: The Connexin Mimetic Peptide Gap27 and Cx43-Knockdown Reveal Differential Roles for Connexin43 in Wound Closure Events in Skin Model Systems. International journal of molecular sciences 2018, 19(2).
7. Monteforte AJ, Lam B, Das S, Mukhopadhyay S, Wright CS, Martin PE, Dunn AK, Baker AB: Glypican-1 nanoliposomes for potentiating growth factor activity in therapeutic angiogenesis. Biomaterials 2016, 94:45-56.
8. Lorraine C, Wright CS, Martin PE: Connexin43 plays diverse roles in co-ordinating cell migration and wound closure events. Biochem Soc Trans 2015, 43(3):482-488.
9. Martin PE: Connexins help fill the Gap: markers and therapeutic targets for chronic nonhealing wounds. Br J Dermatol 2015, 173(5):1123-1124.
10. Wright CS, Berends RF, Flint DJ, Martin PE: Cell motility in models of wounded human skin is improved by Gap27 despite raised glucose, insulin and IGFBP-5. Exp Cell Res 2013, 319(4):390-401.
11. Wright CS, Pollok S, Flint DJ, Brandner JM, Martin PE: The connexin mimetic peptide Gap27 increases human dermal fibroblast migration in hyperglycemic and hyperinsulinemic conditions in vitro. J Cell Physiol 2012, 227(1):77-87.
12. Pollok S, Pfeiffer AC, Lobmann R, Wright CS, Moll I, Martin PE, Brandner JM: Connexin 43 mimetic peptide Gap27 reveals potential differences in the role of Cx43 in wound repair between diabetic and non-diabetic cells. J Cell Mol Med 2011, 15(4):861-873.